156 related articles for article (PubMed ID: 29282894)
1. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.
Swaika A; Frank RD; Yang D; Finn LE; Jiang L; Advani P; Chanan-Khan AA; Ailawadhi S; Foran JM
Cancer Med; 2018 Feb; 7(2):499-507. PubMed ID: 29282894
[TBL] [Abstract][Full Text] [Related]
2. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD
Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Differences in Socioeconomic Position and Risk of Childhood Acute Lymphoblastic Leukemia.
Wang L; Gomez SL; Yasui Y
Am J Epidemiol; 2017 Jun; 185(12):1263-1271. PubMed ID: 28369160
[TBL] [Abstract][Full Text] [Related]
5. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
Zhong J; Yu X; Zhang X
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
[TBL] [Abstract][Full Text] [Related]
7. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patients.
Petit B; Mele L; Rack K; Camera A; Vekemans MC; Bassan R; Pulsoni A; Delannoy A; Pagano L
Leuk Lymphoma; 2002 Aug; 43(8):1599-604. PubMed ID: 12400602
[TBL] [Abstract][Full Text] [Related]
9. SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia.
McNeil DE; Coté TR; Clegg L; Mauer A
Med Pediatr Oncol; 2002 Dec; 39(6):554-7; discussion 552-3. PubMed ID: 12376977
[TBL] [Abstract][Full Text] [Related]
10. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic differences in upper-tract urothelial cancer.
Hosain GM; Khan MM; Amiel GE; Lerner SP; Latini DM; Chen GJ
Ethn Dis; 2012; 22(3):295-301. PubMed ID: 22870572
[TBL] [Abstract][Full Text] [Related]
12. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Ailawadhi S; Azzouqa AG; Hodge D; Cochuyt J; Jani P; Ahmed S; Sher T; Roy V; Ailawadhi M; Alegria VR; Manochakian R; Vishnu P; Grover A; Abdulazeez MF; Paulus A; Chanan-Khan A
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):619-623. PubMed ID: 31377212
[TBL] [Abstract][Full Text] [Related]
13. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
14. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
16. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.
Barnholtz-Sloan JS; Maldonado JL; Williams VL; Curry WT; Rodkey EA; Barker FG; Sloan AE
J Neurooncol; 2007 Nov; 85(2):171-80. PubMed ID: 17530174
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in testicular cancer in the United States: descriptive epidemiology.
Li Y; Lu Q; Wang Y; Ma S
BMC Cancer; 2020 Apr; 20(1):284. PubMed ID: 32252689
[TBL] [Abstract][Full Text] [Related]
18. Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.
Ward-Peterson M; Acuña JM; Alkhalifah MK; Nasiri AM; Al-Akeel ES; Alkhaldi TM; Dawari SA; Aldaham SA
Medicine (Baltimore); 2016 Apr; 95(17):e3315. PubMed ID: 27124020
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
